Menu Search
Equities

Polynovo Ltd

PNV:ASX

Polynovo Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)2.08
  • Today's Change-0.12 / -5.45%
  • Shares traded1.08m
  • 1 Year change+56.39%
  • Beta1.8575
Data delayed at least 20 minutes, as of May 17 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Polynovo Ltd had net income fall 312.95% from a loss of 1.19m to a larger loss of 4.92m despite a 59.53% increase in revenues from 41.44m to 66.11m. An increase in the selling, general and administrative costs as a percentage of sales from 71.18% to 81.85% was a component in the falling net income despite rising revenues.
Gross margin94.30%
Net profit margin1.88%
Operating margin0.35%
Return on assets1.71%
Return on equity2.41%
Return on investment1.98%
More ▼

Cash flow in AUDView more

In 2023, Polynovo Ltd increased its cash reserves by 667.71%, or 40.74m. Cash Flow from Financing totalled 48.06m or 72.70% of revenues. In addition the company used 6.61m for operations while cash used for investing totalled 848.77k.
Cash flow per share0.0056
Price/Cash flow per share390.81
Book value per share0.10
Tangible book value per share0.0986
More ▼

Balance sheet in AUDView more

Polynovo Ltd appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio5.01
Quick ratio4.52
Total debt/total equity0.222
Total debt/total capital0.1817
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.